Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.65
Bid: 148.50
Ask: 152.80
Change: 0.00 (0.00%)
Spread: 4.30 (2.896%)
Open: 150.65
High: 150.65
Low: 150.65
Prev. Close: 150.65
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of the 2016 Bank of England Stress Tests

30 Nov 2016 07:22

RNS Number : 5188Q
Santander UK Plc
30 November 2016
 

30 November 2016

 

 

SANTANDER UK PLC

 

STATEMENT ON THE OUTCOME OF THE 2016

BANK OF ENGLAND STRESS TESTS

 

 

Santander UK notes the publication of the results of the 2016 stress tests conducted on seven major UK banks and building societies by the Bank of England.

 

As a result of the exercise the Bank of England does not require Santander UK to undertake any actions.

 

Santander UK's lowest post-stress CRD IV end-point common equity tier 1 ('CET 1') capital ratio, over a five-year stress period to the end of 2020, was modelled to be 9.9% after allowed management actions. This result is significantly in excess of the CET 1 hurdle rate of 7.3% established by the Bank of England. Santander UK reported a CET 1 capital ratio of 11.1% as at 30 September 2016.

 

The Bank of England's CET1 hurdle rate comprises the CRR Pillar 1 minimum of 4.5% together with a Pillar 2a CET1 minimum of 2.8%. Santander UK plc has been informed that the latter minimum will take force on 1st January 2017 and represents an increase of 0.6 percentage points over the current Pillar 2a CET1 minimum of 2.2%, which will be in force until 31st December 2016.

 

Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2020, was modelled to be 3.6% after allowed management actions. This result is significantly in excess of the leverage threshold of 3.0% established by the Bank of England. Santander UK reported a leverage ratio of 4.0%1 as at 30 September 2016.

 

1 The end point CRD IV Tier 1 Leverage Ratio at 30 September 2016 would have been 3.8%, based upon leverage exposure of £301.9bn, if the deductions permitted under the Recommendation from the Financial Policy Committee on the 25th July 2016 were excluded.

 

- Ends -

 

Santander UK is a financial services provider in the UK that offers a wide range of personal and commercial financial products and services. As at 30 June 2016, the bank serves around 14 million active customers with c. 20,000 employees and operates through 841 branches (which includes 58 university branches) and 69 regional Corporate Business Centres. Santander UK is subject to the full supervision of the Financial Conduct Authority (FCA) and Prudential Regulation Authority (PRA) in the UK. Santander UK plc customers are protected by the Financial Services Compensation Scheme (FSCS) in the UK.

 

About Us

Banco Santander (SAN SM, STD US, BNC LN) is a leading retail and commercial bank, based in Spain, with a meaningful market share in 10 core countries in Europe and the Americas. Santander is among the world's top banks by market capitalization. Founded in 1857, Santander had EUR 1.52 trillion in managed funds, 12,500 branches and 190,000 employees at the close of June 2016. In the first half of 2016, Santander made underlying profit of EUR 3,280 million.

 

Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

For further information please contact:

Andy Smith, Head of Media Relations Tel: +44 (0) 20 7756 4212

Bojana Flint, Head of Investor Relations Tel: +44 (0) 20 7756 6474

For more information: www.aboutsantander.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFFDLILIVIR
Date   Source Headline
22nd Jan 20184:58 pmRNSArticle 8
22nd Jan 20183:02 pmRNS1119 ISE Delisting announcement
16th Jan 20184:45 pmRNSPublication of Final Terms
11th Jan 201812:04 pmRNSPublication of Final Terms
3rd Jan 201811:25 amRNSArticle 8
27th Dec 20172:25 pmRNSNotice of Early Redemption
21st Dec 20171:15 pmRNSDirectorate Change
14th Dec 20177:47 amRNSXS1656513832 - 1116 Delisting
12th Dec 20179:00 amRNSXS1656513832 - 1116 ISE Delisting
11th Dec 20175:34 pmRNSArticle 8
8th Dec 20178:03 amRNSArticle 8
27th Nov 20175:14 pmRNSNotice of Early Redemption
27th Nov 201711:06 amRNSDirectorate Change
17th Nov 20174:23 pmRNSPublication of Final Terms
26th Oct 20173:12 pmRNSPublication of Suppl.Prospcts
26th Oct 20173:10 pmRNSPublication of Suppl.Prospcts
26th Oct 20177:15 amRNS3rd Quarter Results
23rd Oct 201712:03 pmRNSDelisting
16th Oct 20175:51 pmRNSNotice of Substitution of Issuer
16th Oct 20175:47 pmRNSNotice of Substitution of Issuer
16th Oct 20175:46 pmRNSNotice of Substitution of Issuer
16th Oct 20171:09 pmRNSRing-Fencing Update
13th Oct 20173:46 pmRNSPublication of Final Terms
27th Sep 20171:07 pmRNSPublication of Final Terms
20th Sep 201712:51 pmRNSPublication of Final Terms
19th Sep 20174:25 pmRNSPurchase & Cancellation of Notes
14th Sep 20176:32 pmRNSPublication of Suppl.Prospcts
14th Sep 20176:28 pmRNSPublication of Suppl.Prospcts
14th Sep 20177:15 amRNSHalf-year Report
14th Sep 20177:15 amRNSHalf-year Report
12th Sep 201711:53 amRNSNotice of Delisting XS1606968771
1st Sep 20173:10 pmRNSPublication of Final Terms
31st Aug 20177:00 amRNSPublication of a Prospectus
31st Aug 20177:00 amRNSPublication of a Prospectus
28th Jul 20174:52 pmRNSGlobal Covered Bond Programme Supplement
28th Jul 20174:50 pmRNSMedium Term Note Programme Supplement
28th Jul 20177:15 amRNSQMS for 6 months ending 30 June 2017
14th Jul 20172:05 pmRNSNotice of Delisting
2nd Jun 20175:47 pmRNSPublication of a Prospectus
22nd May 201710:52 amRNSDirectorate Change
19th May 20172:12 pmRNSNotice of Delisting XS1561800175
18th May 201711:02 amRNSPublication of Final Terms
4th May 20174:17 pmRNSPublication of Final Terms
26th Apr 20176:27 pmRNSPublication of Suppl.Prospcts
26th Apr 20175:58 pmRNSPublication of Suppl.Prospcts
26th Apr 20177:30 amRNS1st Quarter Results
6th Apr 20176:30 pmRNSPublication of a Prospectus
31st Mar 20172:45 pmRNSResult of AGM
10th Mar 201711:56 amRNSPublication of Final Terms
23rd Feb 20175:40 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.